ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
101 hedge funds and large institutions have $228M invested in Endocyte, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 40 increasing their positions, 33 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
80% less call options, than puts
Call options by funds: $935K | Put options by funds: $4.79M
Holders
101
Holding in Top 10
–
Calls
$935K
Puts
$4.79M
Top Buyers
| 1 | +$16.9M | |
| 2 | +$8.29M | |
| 3 | +$6.4M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$4.66M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$2.19M |
Top Sellers
| 1 | -$8.69M | |
| 2 | -$4.4M | |
| 3 | -$2.38M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$2.04M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$2.04M |